Induction therapy for elderly patients with acute myeloid leukemia

Mike G. Martin, Camille N. Abboud

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Acute myeloid leukemia (AML) is a disease of older adults. Efforts to intensify therapy along traditional avenues have failed to yield improved results. There remains significant clinical equipoise as to how to "induce" patients and whether or not 7 + 3-style regimens improve outcomes over low-dose cytarabine. What is certain is that even in those not receiving active therapy, AML is an exceptionally morbid disease. Diverse interventions are being explored in the management of older patients with AML and the currently available data will be reviewed.

Original languageEnglish
Pages (from-to)311-320
Number of pages10
JournalBlood Reviews
Issue number6
StatePublished - Nov 1 2008


  • Acute myeloid leukemia
  • Elderly
  • Induction therapy
  • Review

Fingerprint Dive into the research topics of 'Induction therapy for elderly patients with acute myeloid leukemia'. Together they form a unique fingerprint.

Cite this